BOSTON – October 7, 2025 – AcuityMD, the AI platform for MedTech, announced today at its annual Flywheel event for commercial leaders a major expansion of its platform with new AI tools to give medical device companies visibility into forecasted sales performance, business risks, and next-best actions to reach their goals. AcuityMD is modernizing how MedTech companies go to market by applying AI to improve efficiency and effectiveness – ultimately accelerating the delivery of life-changing medical innovations to patients.
In today’s competitive market, MedTech commercial teams face constant pressure to hit sales targets, but fragmented tools and incomplete data make it hard to forecast accurately and prioritize the right opportunities. AcuityMD solves this by delivering reliable forecasts and AI-driven action plans that help leaders focus resources, guide reps to the best opportunities, and accelerate revenue growth.
Built on AcuityMD’s foundation of real-world market data and advanced targeting technology, the new AI enhancements add a powerful layer of insights plus guided execution that continuously adapt and improve over time. With AcuityMD, MedTech companies can now:
“Most forecasting tools stop at projecting outcomes,” said Brian Collins, Chief Product Officer at AcuityMD. “Our platform goes further by showing teams how to achieve outcomes. Together with our customers, we’re applying AI to bring clarity, focus, and faster adoption of medical technology.”
Corza Biosurgery Area Sales Director Pat O’Brien added, “Our sales data was spread across multiple platforms, which created a significant administrative burden and made it difficult for leadership to track performance to quota.” Fellow Area Sales Director Kara Dillon concluded, “AcuityMD has given us the ability to instantly assess sales performance, support our reps where needed, and create more accurate quotas based on real data.”
